MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...
Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the U.S. military, ...
ST. LOUIS – From a hospital to housing complexes, some of our area’s largest institutions are behind on their utility bills. Thousands of account holders owe more than $100 million owed to the ...
America is the land of the free and of V8s. While turbocharging is great and all, most of us dream of a large, hunking V8 that sounds glorious, leaves unending skid marks, and offers the thrust of a ...
MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...
CASE, PLEASE CALL THAT POLICE TIP LINE. LOUISVILLE’S MSD BOARD HAS APPROVED A WASTEWATER RATE INCREASE WHICH WILL AFFECT RESIDENTS IN JEFFERSON AND OLDHAM COUNTIES. SO HOW MUCH ARE WE TALKING ABOUT?
Eastdil Secured hired BDT & MSD Partners to advise the firm on potential strategic partnerships and growth initiatives, according to a memo seen by Bloomberg News. Eastdil said it’s tapping BDT & MSD ...
Hyderabad: US pharma giant Merck & Co Inc, which does business as Merck Sharp & Dohme (MSD) outside the United States and Canada, opened its first technology centre in India at Hyderabad this week, ...
BDT & MSD Partners proposes a 60-unit condominium at Boca Raton Resort & Club, amid a development frenzy for luxury projects in South Florida. The merchant bank, which has offices in New York and ...
Pharma giant MSD is buying the Dundalk-based vaccines plant of Chinese rival Wuxi in a €500 million deal. Wuxi invested €200 million in 2019 to build the plant, which currently employs 200 people, ...
Clesrovimab is a single dose extended half-life monoclonal antibody developed as a passive immunisation for the prevention of RSV. Image credit: Sergiy Palamarchuk / Shutterstock. MSD (Merck & Co) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback